Hyperthermic intraperitoneal chemotherapy as consolidation treatment of advanced stage ovarian cancer
Objective To investigate the therapeutic efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) as consolidation treatment after completing first-line treatment in patients with advanced ovarian cancer. Methods A retrospective chart review was conducted on patients treated at the Comprehensiv...
Main Authors: | Jieun Ko, Hyeong In Ha, Min Chul Choi, Sang Geun Jung, Hyun Park, Won Duk Joo, Seung Hun Song, Chan Lee, Joon Mo Lee |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Society of Obstetrics and Gynecology
2021-09-01
|
Series: | Obstetrics & Gynecology Science |
Subjects: | |
Online Access: | http://www.ogscience.org/upload/pdf/ogs-21093.pdf |
Similar Items
-
Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients
by: Wu-yun Wang, et al.
Published: (2021-01-01) -
Feasibility and safety of neoadjuvant laparoscopic hyperthermic intraperitoneal chemotherapy in patients with advanced stage ovarian cancer: a single-center experience
by: Gao T, et al.
Published: (2019-07-01) -
Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites
by: Jie Jiao, et al.
Published: (2020-07-01) -
OUR EXPERIENCE OF HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH ADVANCED GASTRIC CANCER
by: A. D. Kaprin, et al.
Published: (2016-01-01) -
Anesthetic implications in hyperthermic intraperitoneal chemotherapy
by: Nishkarsh Gupta, et al.
Published: (2019-01-01)